Cover Image

<i>Acinetobacter baumannii</i> Infections in Hospitalized Patients, Treatment Outcomes

<i>Background Acinetobacter baumannii</i> (AB), an opportunistic pathogen, could develop into serious infections with high mortality and financial burden. The debate surrounding the selection of effective antibiotic treatment necessitates studies to define the optimal approach. This stud...

Full description

Saved in:

Bibliographic Details
Main Authors:	Diaa Alrahmany (Author), Ahmed F. Omar (Author), Gehan Harb (Author), Wasim S. El Nekidy (Author), Islam M. Ghazi (Author)
Format:	Book
Published:	MDPI AG, 2021-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

<i>Acinetobacter baumannii</i> Infection-Related Mortality in Hospitalized Patients: Risk Factors and Potential Targets for Clinical and Antimicrobial Stewardship Interventions
by: Diaa Alrahmany, et al.
Published: (2022)

Risk Factors for Recurrence of Clostridioides difficile in Hospitalized Patients
by: Diaa Alrahmany, et al.
Published: (2021)

Infections in Glucose-6-Phosphate Dehydrogenase G6PD-Deficient Patients; Predictors for Infection-Related Mortalities and Treatment Outcomes
by: Diaa Alrahmany, et al.
Published: (2023)

Infections in G6PD-Deficient Hospitalized Patients-Prevalence, Risk Factors, and Related Mortality
by: Diaa Alrahmany, et al.
Published: (2022)

Treatment Strategies of Colistin Resistance <i>Acinetobacter baumannii</i> Infections
by: Andria Papazachariou, et al.
Published: (2024)

Clinical Outcomes of Ceftazidime-Avibactam versus Ceftolozane-Tazobactam in Managing Pseudomonal Infections in Patients Undergoing Renal Replacement Therapy
by: Wasim S. El Nekidy, et al.
Published: (2024)

<i>Acinetobacter</i> Non-<i>baumannii</i> Species: Occurrence in Infections in Hospitalized Patients, Identification, and Antibiotic Resistance
by: Eugene Sheck, et al.
Published: (2023)

An Update on the Therapeutic Potential of Antimicrobial Peptides against <i>Acinetobacter baumannii</i> Infections
by: Karyne Rangel, et al.
Published: (2023)

Pregnancy and Perinatal Outcomes Associated with Acinetobacter baumannii Infection
by: Mai He, et al.
Published: (2013)

Phage φAB6-Borne Depolymerase Combats <i>Acinetobacter baumannii</i> Biofilm Formation and Infection
by: Md. Shahed-, et al.
Published: (2021)

Interaction of <i>Acinetobacter baumannii</i> with Human Serum Albumin: Does the Host Determine the Outcome?
by: Camila Pimentel, et al.
Published: (2021)

Inhibition of <i>Acinetobacter baumannii</i> Biofilm Formation Using Different Treatments of Silica Nanoparticles
by: Iyad Y. Natsheh, et al.
Published: (2023)

The Impact of Antimicrobial Stewardship and Infection Control Interventions on <i>Acinetobacter baumannii</i> Resistance Rates in the ICU of a Tertiary Care Center in Lebanon
by: Nesrine A. Rizk, et al.
Published: (2022)

Gastrointestinal Colonization of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: What Is the Implication for Infection Control?
by: Shuk-Ching Wong, et al.
Published: (2022)

Minocycline and the SPR741 Adjuvant Are an Efficacious Antibacterial Combination for <i>Acinetobacter baumannii</i> Infections
by: Yonas A. Alamneh, et al.
Published: (2022)

Novel Phage Lysin Abp013 against <i>Acinetobacter baumannii</i>
by: Joash Jun Keat Chu, et al.
Published: (2022)

Colistin Resistance in <i>Acinetobacter baumannii:</i> Molecular Mechanisms and Epidemiology
by: Katarina Novović, et al.
Published: (2023)

Pan-Resistome Insights into the Multidrug Resistance of <i>Acinetobacter baumannii</i>
by: Diego Lucas Neres Rodrigues, et al.
Published: (2021)

DksA Modulates Antimicrobial Susceptibility of <i>Acinetobacter baumannii</i>
by: Nayeong Kim, et al.
Published: (2021)

<i>Acinetobacter baumannii</i> Resistance: A Real Challenge for Clinicians
by: Rosalino Vázquez-López, et al.
Published: (2020)

Investigating Bacteriophages Targeting the Opportunistic Pathogen <i>Acinetobacter baumannii</i>
by: Kathryn M. Styles, et al.
Published: (2020)

Prosthetic valve endocarditis caused by <i> Acinetobacter baumannii </i> complex
by: Kumar S, et al.
Published: (2008)

Multidrug-Resistant <i>Acinetobacter baumannii</i> Infections in the United Kingdom versus Egypt: Trends and Potential Natural Products Solutions
by: Wafaa H. Elwakil, et al.
Published: (2023)

Is It Possible to Eradicate Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) from Endemic Hospitals?
by: Filippo Medioli, et al.
Published: (2022)

The RND Efflux Pump Gene Expression in the Biofilm Formation of <i>Acinetobacter baumannii</i>
by: Ola A. Abd El-Rahman, et al.
Published: (2023)

Acinetobacter baumannii Infection in the Neonatal Intensive Care Unit
by: AMK AL Jarousha, et al.
Published: (2008)

Control of Healthcare-Associated Carbapenem-Resistant <i>Acinetobacter baumannii</i> by Enhancement of Infection Control Measures
by: Shuk-Ching Wong, et al.
Published: (2022)

Current Therapeutic Approaches for Multidrug-Resistant and Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Infections
by: Petros Rafailidis, et al.
Published: (2024)

The Characterisation of Carbapenem-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> in a Teaching Hospital in Malaysia
by: Min Yi Lau, et al.
Published: (2024)

<i>Acinetobacter baumannii</i> Resistance to Sulbactam/Durlobactam: A Systematic Review
by: Luigi Principe, et al.
Published: (2022)

Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Arta Karruli, et al.
Published: (2023)

The Role of Uniform Meropenem Usage in <i>Acinetobacter baumannii</i> Clone Replacement
by: Bence Balázs, et al.
Published: (2021)

Antibiotic Resistance and Genotypes of Nosocomial Strains of <i>Acinetobacter baumannii</i> in Kazakhstan
by: Alyona Lavrinenko, et al.
Published: (2021)

Biofilm-Induced Antibiotic Resistance in Clinical <i>Acinetobacter baumannii</i> Isolates
by: Abebe Mekuria Shenkutie, et al.
Published: (2020)

Efficacy of Lysophosphatidylcholine as Direct Treatment in Combination with Colistin against <i>Acinetobacter baumannii</i> in Murine Severe Infections Models
by: Andrea Miró-Canturri, et al.
Published: (2021)

Current State of Antimicrobial Treatment of Lower Respiratory Tract Infections Due to Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Marco Merli, et al.
Published: (2023)

<i>Pimenta</i> Oil as a Potential Treatment for <i>Acinetobacter baumannii</i> Wound Infection: In Vitro and In Vivo Bioassays in Relation to Its Chemical Composition
by: Maha M. Ismail, et al.
Published: (2020)

Dynamic Gene Clusters Mediating Carbapenem-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates
by: Samy Selim, et al.
Published: (2022)

Molecular Characterization of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolated from Intensive Care Unit Patients in Jordanian Hospitals
by: Suhaila A. Al-Sheboul, et al.
Published: (2022)

RapidResa Polymyxin <i>Acinetobacter</i> NP<sup>®</sup> Test for Rapid Detection of Polymyxin Resistance in <i>Acinetobacter baumannii</i>
by: Maxime Bouvier, et al.
Published: (2021)